• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚睾丸生殖细胞癌发病率的趋势。

Trends in testicular germ cell cancer incidence in Australia.

作者信息

Baade Peter, Carrière P, Fritschi L

机构信息

Viertel Centre for Research in Cancer Control, The Cancer Council Queensland, Spring Hill, QLD, Australia.

出版信息

Cancer Causes Control. 2008 Dec;19(10):1043-9. doi: 10.1007/s10552-008-9168-z. Epub 2008 May 14.

DOI:10.1007/s10552-008-9168-z
PMID:18478339
Abstract

OBJECTIVE

Although increasing incidence of testicular germ cell cancer has been reported in many developed nations, national estimates for Australia, with histological differentiation, are not currently available.

METHODS

Using data from all state and territory population-based cancer registries in Australia, this paper reports on incidence trends for seminomas and non-seminomas in Australia between 1982 and 2004 using Joinpoint and Age-Period-Cohort models.

RESULTS

Of the 10,528 testicular germ cell cancers diagnosed during this period, 6086 (58%) were seminomas. Incidence rates have increased (2.6% per year) in Australia since 1982, with the effect stronger among seminomas (3.4% per year) rather than non-seminomas (1.4% per year). There was a strong age effect evident for both subtypes, peaking in the 25-29 year age group for non-seminomas and the 30-34 year age group for seminomas. Non-seminoma rates reflected a significant birth cohort effect, following a U-shaped pattern with the lowest risk among the 1,945 birth cohort.

CONCLUSIONS

The differential trends observed for Australia for seminomas and non-seminomas are consistent with those reported for the United States, but slightly different to those reported for Europe. The trends may be at least partly due to changes over time in the prevalence of etiologic or protective factors around the time of birth.

摘要

目的

尽管许多发达国家报告睾丸生殖细胞癌的发病率在上升,但目前尚无澳大利亚按组织学分化的全国性估计数据。

方法

利用澳大利亚所有州和地区基于人群的癌症登记处的数据,本文使用Joinpoint和年龄-时期-队列模型报告了1982年至2004年澳大利亚精原细胞瘤和非精原细胞瘤的发病趋势。

结果

在此期间诊断出的10528例睾丸生殖细胞癌中,6086例(58%)为精原细胞瘤。自1982年以来,澳大利亚的发病率有所上升(每年2.6%),精原细胞瘤的上升幅度更大(每年3.4%),而非精原细胞瘤为(每年1.4%)。两种亚型都有明显的年龄效应,非精原细胞瘤在25-29岁年龄组达到峰值,精原细胞瘤在30-34岁年龄组达到峰值。非精原细胞瘤发病率反映出显著的出生队列效应,呈U形模式,1945年出生队列的风险最低。

结论

澳大利亚精原细胞瘤和非精原细胞瘤观察到的不同趋势与美国报告的趋势一致,但与欧洲报告的趋势略有不同。这些趋势可能至少部分归因于出生前后病因或保护因素流行率随时间的变化。

相似文献

1
Trends in testicular germ cell cancer incidence in Australia.澳大利亚睾丸生殖细胞癌发病率的趋势。
Cancer Causes Control. 2008 Dec;19(10):1043-9. doi: 10.1007/s10552-008-9168-z. Epub 2008 May 14.
2
Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996.1964年至1996年安大略省睾丸生殖细胞癌按组织学亚组划分的发病率趋势
CMAJ. 1999 Jan 26;160(2):201-5.
3
Population based incidence and age distribution of spermatocytic seminoma.基于人群的精母细胞性精原细胞瘤的发病率及年龄分布。
J Urol. 2007 Jul;178(1):125-8. doi: 10.1016/j.juro.2007.03.024. Epub 2007 May 11.
4
Testicular cancer incidence in eight northern European countries: secular and recent trends.八个北欧国家的睾丸癌发病率:长期及近期趋势
Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2157-66.
5
Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries.睾丸精原细胞瘤和非精原细胞瘤的病因相同吗?来自八个欧洲国家发病率趋势的年龄-时期-队列分析的证据。
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):652-8. doi: 10.1158/1055-9965.EPI-05-0565.
6
Subtype-specific incidence of testicular cancer in Germany: a pooled analysis of nine population-based cancer registries.德国睾丸癌的亚型特异性发病率:九个基于人群的癌症登记处的汇总分析。
Int J Androl. 2009 Aug;32(4):306-16. doi: 10.1111/j.1365-2605.2007.00850.x. Epub 2007 Dec 30.
7
Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma?睾丸癌的危险因素——纯非精原细胞瘤与混合性精原细胞瘤/非精原细胞瘤之间的差异?
Int J Androl. 2006 Aug;29(4):458-67. doi: 10.1111/j.1365-2605.2005.00632.x. Epub 2006 Feb 20.
8
Testicular cancer in Luxembourg: incidence and outcome in relation to the different histo-pathological types (1980-2004).卢森堡的睾丸癌:与不同组织病理学类型相关的发病率及转归(1980 - 2004年)
Bull Soc Sci Med Grand Duche Luxemb. 2008(4):521-39.
9
Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.睾丸癌:对某地区军事医疗设施20年经验的流行病学回顾。
J Urol. 2008 Aug;180(2):577-81; discussion 581-2. doi: 10.1016/j.juro.2008.04.032. Epub 2008 Jun 12.
10
[The epidemiology of tumors of the testes in the Netherlands: accurate rendering by the Registry of Histopathology and Cytopathology (PALGA)].[荷兰睾丸肿瘤的流行病学:组织病理学和细胞病理学登记处(PALGA)的准确呈现]
Ned Tijdschr Geneeskd. 2004 Jun 5;148(23):1150-4.

引用本文的文献

1
The increasing burden of testicular seminomas and non-seminomas in adolescents and young adults (AYAs): incidence, treatment, disease-specific survival and mortality trends in the Netherlands between 1989 and 2019.青少年和年轻成年人(AYAs)中睾丸精原细胞瘤和非精原细胞瘤负担增加:1989 年至 2019 年荷兰的发病率、治疗、疾病特异性生存和死亡率趋势。
ESMO Open. 2024 Feb;9(2):102231. doi: 10.1016/j.esmoop.2023.102231. Epub 2024 Jan 19.
2
Assessment of the Emerging Threat Posed by Perfluoroalkyl and Polyfluoroalkyl Substances to Male Reproduction in Humans.评估全氟烷基和多氟烷基物质对人类男性生殖的新出现威胁。
Front Endocrinol (Lausanne). 2022 Mar 9;12:799043. doi: 10.3389/fendo.2021.799043. eCollection 2021.
3
Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.
美国睾丸生殖细胞肿瘤发病率的未来:至2026年的预测
Cancer. 2017 Jun 15;123(12):2320-2328. doi: 10.1002/cncr.30597. Epub 2017 Feb 27.
4
Long-term outcomes following post-operative radiotherapy for Stage I/II testicular seminoma - an Australasian single-institution experience.I/II期睾丸精原细胞瘤术后放疗的长期疗效——一项澳大利亚单机构经验
J Med Radiat Sci. 2016 Sep;63(3):161-9. doi: 10.1002/jmrs.170. Epub 2016 Apr 5.
5
Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis.大麻暴露与睾丸癌风险:一项系统评价和荟萃分析。
BMC Cancer. 2015 Nov 11;15:897. doi: 10.1186/s12885-015-1905-6.
6
"Off-Label" Usage of Testicular Self-Examination (TSE): Benefits Beyond Cancer Detection.睾丸自我检查(TSE)的“超说明书”用法:超越癌症检测的益处
Am J Mens Health. 2018 May;12(3):505-513. doi: 10.1177/1557988315584942. Epub 2015 May 19.
7
The rise of testicular germ cell tumours: the search for causes, risk factors and novel therapeutic targets.睾丸生殖细胞肿瘤的发病率上升:对病因、风险因素及新型治疗靶点的探索。
F1000Res. 2013 Feb 19;2:55. doi: 10.12688/f1000research.2-55.v1. eCollection 2013.
8
Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant.睾丸生殖细胞肿瘤的显著日历时间偏差表明,出生后暴露与发病机制有关。
Cancer Causes Control. 2012 Oct;23(10):1593-8. doi: 10.1007/s10552-012-0036-5. Epub 2012 Jul 28.
9
Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options.睾丸内生殖细胞肿瘤与双侧睾丸肿瘤:临床意义及处理选择
Indian J Urol. 2010 Jan-Mar;26(1):64-71. doi: 10.4103/0970-1591.60454.
10
International trends in the incidence of testicular cancer, 1973-2002.国际睾丸癌发病率趋势,1973-2002 年。
Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1151-9. doi: 10.1158/1055-9965.EPI-10-0031.